Skip to main content

and
  1. No Access

    Article

    Coherent X-ray diffraction imaging meets ptychography to study core-shell-shell nanowires

    We report on the results of coherent X-ray diffraction imaging (CXDI) and ptychography measurements of two individual core-shell-shell GaAs/(In,Ga)As/GaAs nanowires (NWs) grown by molecular beam epitaxy (MBE) ...

    A. Davtyan, V. Favre-Nicolin, R. B. Lewis, H. Küpers, L. Geelhaar in MRS Advances (2018)

  2. No Access

    Article

    Sequential FOLFOX-6 and gemcitabine for locally advanced and/or metastatic pancreatic cancer

    This prospective phase II trial aims to evaluate the sequential FOLFOX-6 and gemcitabine followed by adapted maintenance for advanced pancreatic cancer. Treatment included FOLFOX-6 for 4 cycles, followed seque...

    M. Ghosn, A. Saroufim, J. Kattan, G. Chahine, F. Nasr, F. Farhat in Medical Oncology (2012)

  3. No Access

    Article

    A phase II randomized study comparing navelbine and capecitabine (Navcap) followed either by Navcap or by weekly docetaxel in the first-line treatment of HER-2/neu negative metastatic breast cancer

    Following the proven efficacy and tolerability of Navcap and Navcap followed by docetaxel in the treatment of MBC, a phase II randomized study was initiated to assess the ORR of both arms in the first-line set...

    M. Ghosn, P. Aftimos, F. S. Farhat, J. G. Kattan, C. Hanna, N. Haddad in Medical Oncology (2011)

  4. No Access

    Article

    Phase I trial of Idarubicin (4-demethoxydaunorubicin) in adult acute leukemia

    Idarubicin (IDR) is a new analog of Daunorubicin (DNR) selected for clinical trials because of its outstanding activity in experimental leukemias of mice and in several experimental models when compared to DNR...

    M. Hayat M.D., P. Hurteloup, C. Parmentier, P. Carde in Investigational New Drugs (1984)